Substituted [1,2,3]triazolo[4,5-D]pyrimidines as CDK inhibitors

Patent No.: 
US7816350
Patented in: 
USA/USPTO
Authors: 
Fuksová K, Havlíček L, Kryštof V, Lenobel R, Strnad M
Patent owner: 
ÚEB AV ČR, UPOL
Date of the patent application: 
19.10.2010
Registration year: 
2010
IEB Authors: 
Libor Havlíček
Vladimír Kryštof
René Lenobel
Miroslav Strnad